Nitinotes Expands U.S. Obesity Trial at Weill Cornell Center
CAESAREA, Israel, August 13, 2026 Nitinotes Ltd., a medical device company developing automated endoluminal suturing technologies for obesity treatment,...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
CAESAREA, Israel, August 13, 2026 Nitinotes Ltd., a medical device company developing automated endoluminal suturing technologies for obesity treatment,...
Redwood City, California, August,11, 2026 Galvanize Therapeutics, Inc. has announced the completion of the first commercial procedures using its...
Beijing, China, August,11, 2026 Datasea Intelligent Technology Ltd. has announced that its variable interest entity, Shuhai Jingwei (Shenzhen) Information...
Thousand Oaks, California & Salt Lake City, Utah, August, 10, 2026 Teledyne Technologies Incorporated and Varex Imaging Corporation have...
Chicago, Illinois, USA, August 10, 2026 Beltone has announced Beltone Illuminateâ„¢, a new family of premium hearing aids designed...
Irvine, California, USA, August 7, 2026 Tarsus Pharmaceuticals has announced a definitive agreement to acquire Alkeus Pharmaceuticals, a privately...
Amsterdam, Netherlands, August 7, 2026 Royal Philips has expanded its open patient monitoring ecosystem through a series of strategic...
New York, August 5, 2026 Schrödinger, Inc. has entered into a strategic collaboration and software agreement with Bristol Myers...
Osaka, Japan and Bridgewater, New Jersey, August 4, 2026 NIPRO CORPORATION, through its U.S.-based subsidiary NIPRO Medical Corporation, has...
Cambridge, Massachusetts – August 4, 2026 Moderna, Inc. has announced the initiation of a Phase 1 clinical trial evaluating...
